venBio Global Strategic GP II, L.P.
10% owner at Checkmate Pharmaceuticals, Inc.; 10% owner at AKRO
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Apr 26, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Checkmate Pharmaceuticals, Inc.10% owner
- AKROAkero Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Checkmate Pharmaceuticals, Inc.129,781 shares
- AKRO15,930 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AKROPlan not statedFeb 12 2020
Sold 10,026 shares at $27.07 ($271k)
venBio Global Strategic GP II, L.P., 10% owner
Sold 0.3% of holdings ($87.8M position)3.2M shares leftFirst sale on recordFiling
- 2 Form 4 sale AKROPlan not statedFeb 27 +15 days
Sold 5,904 shares at $22.80 ($135k)
venBio Global Strategic GP II, L.P., 10% owner
Sold 0.2% of holdings ($73.7M position)3.2M shares leftFiling
- 3 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedApr 26 +789 days
Sold 129,781 shares at $10.39 ($1.3M)
venBio Global Strategic GP II, L.P., 10% owner
Sold 4.2% of holdings ($32.5M position)3M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 129,781 | $1.3M | 4.2% | Plan not stated | SEC |
| Feb 27, 2020 | AKRO | 10% owner | Form 4 sale | 5,904 | $135k | 0.2% | Plan not stated | SEC |
| Feb 12, 2020 | AKRO | 10% owner | Form 4 sale | 10,026 | $271k | 0.3% | Plan not stated | SEC |